Skip to main content
. Author manuscript; available in PMC: 2010 Jan 14.
Published in final edited form as: Behav Brain Res. 2009 Mar 3;201(1):216–222. doi: 10.1016/j.bbr.2009.02.021

Fig. 1.

Fig. 1

Effects of the adenosine A2A antagonist KW6002 in combination with 0.1 mg/kg haloperidol. (A) Mean (±S.E.M.) number of lever presses after treatment with vehicle or haloperidol plus various doses of KW6002 are shown. (B) Mean (±S.E.M.) intake of lab chow (in grams) after treatment with vehicle or haloperidol plus various doses of KW6002 are shown. Veh/Veh (vehicle plus vehicle), HP/Veh (0.1 mg/kg haloperidol plus vehicle), HP/KW 0.125 (0.1 mg/kg haloperidol plus 0.125 mg/kg KW6002), HP/KW 0.25 (0.1 mg/kg haloperidol plus 0.125 mg/kg KW6002), HP/KW 0.5 (0.1 mg/kg haloperidol plus 0.5 mg/kg KW6002). #p < 0.01, haloperidol different from vehicle/vehicle, planned comparison; *p < 0.05, different from vehicle plus haloperidol, planned comparison.